Simon Mallal
Simon Mallal
Director, Institute for Immunology and Infectious Diseases, Murdoch University, Western Australia
Verified email at iiid.com.au
Title
Cited by
Cited by
Year
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
19702003
HLA-B* 5701 screening for hypersensitivity to abacavir
S Mallal, E Phillips, G Carosi, JM Molina, C Workman, J Tomažič, ...
New England Journal of Medicine 358 (6), 568-579, 2008
17912008
Association between presence of HLA-B* 5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
S Mallal, D Nolan, C Witt, G Masel, AM Martin, C Moore, D Sayer, ...
The Lancet 359 (9308), 727-732, 2002
15072002
A whole-genome association study of major determinants for host control of HIV-1
J Fellay, KV Shianna, D Ge, S Colombo, B Ledergerber, M Weale, ...
science 317 (5840), 944-947, 2007
12952007
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
10232008
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
P Kiepiela, AJ Leslie, I Honeyborne, D Ramduth, C Thobakgale, S Chetty, ...
Nature 432 (7018), 769-775, 2004
8792004
Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level
CB Moore, M John, IR James, FT Christiansen, CS Witt, SA Mallal
Science 296 (5572), 1439-1443, 2002
8782002
Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection
SA Mallal, M John, CB Moore, IR James, EJ McKinnon
Aids 14 (10), 1309-1316, 2000
5862000
The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases
P Price, C Witt, R Allock, D Sayer, M Garlepp, CC Kok, M French, S Mallal, ...
Immunological reviews 167 (1), 257-274, 1999
5601999
Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy
MA French, N Lenzo, M John, SA Mallal, EJ McKinnon, IR James, P Price, ...
HIV medicine 1 (2), 107-115, 2000
5092000
Predisposition to abacavir hypersensitivity conferred by HLA-B* 5701 and a haplotypic Hsp70-Hom variant
AM Martin, D Nolan, S Gaudieri, CA Almeida, R Nolan, I James, ...
Proceedings of the National Academy of Sciences 101 (12), 4180-4185, 2004
5012004
Adaptation of HIV-1 to human leukocyte antigen class I
Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ...
Nature 458 (7238), 641-645, 2009
5002009
Common genetic variation and the control of HIV-1 in humans
J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ...
PLoS Genet 5 (12), e1000791, 2009
3872009
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
B Ledergerber, PLATO collaboration
The Lancet 364 (9428), 51-62, 2004
3662004
Effects of CCR5-32, CCR2-64I, and SDF-1 3 A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data
IP Data
Ann Intern Med 135, 782-795, 2001
361*2001
Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 …
TM Allen, M Altfeld, SC Geer, ET Kalife, C Moore, KM O'Sullivan, ...
Journal of virology 79 (21), 13239-13249, 2005
3472005
High sensitivity of human leukocyte antigen-b* 5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients
M Saag, R Balu, E Phillips, P Brachman, C Martorell, W Burman, B Stancil, ...
Clinical infectious diseases 46 (7), 1111-1118, 2008
3452008
Predisposition to nevirapine hypersensitivity associated with HLA-DRB1* 0101 and abrogated by low CD4 T-cell counts
AM Martin, D Nolan, I James, P Cameron, J Keller, C Moore, E Phillips, ...
Aids 19 (1), 97-99, 2005
3452005
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
DA Ostrov, BJ Grant, YA Pompeu, J Sidney, M Harndahl, S Southwood, ...
Proceedings of the National Academy of Sciences 109 (25), 9959-9964, 2012
3262012
Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study
A Rauch, D Nolan, A Martin, E McKinnon, C Almeida, S Mallal
Clinical infectious diseases 43 (1), 99-102, 2006
3222006
The system can't perform the operation now. Try again later.
Articles 1–20